Concepedia

Author

Céline Narjoz

Hôpital Européen Georges-PompidouORCID

Also Known As

C Narjoz, C. Narjoz, Celine Narjoz, Cèline Narjoz, Céline Narjoz, celine Narjoz

67

Publications

1.7K

Citations

19

H-Index

71

Concepts

All Affiliations

Hôpital Européen Georges-PompidouUniversité Paris CitéInsermAssistance Publique – Hôpitaux de ParisHôpital Européen
CN

About

Céline Narjoz is an author at Hôpital Européen Georges-Pompidou specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

609

2

Health Sciences

1

1

139

3

Natural Sciences

1

1

11

4

Public Health

1

1

13

5

Biochemistry

1

1

11

Céline Narjoz

×

23

Publications

1.2K

Citations

16

H-Index

YearCitations

Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues

Ivan Bièche, Céline Narjoz, Tarik Asselah,

Pharmacogenetics and Genomics

2007

340

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin

Isabelle Gouin‐Thibault, Xavier Delavenne, Anne Blanchard,

Journal of Thrombosis and Haemostasis

2016

139

<i><scp>UGT</scp>1A1</i> genotype and irinotecan therapy: general review and implementation in routine practice

Marie-Christine Étienne-Grimaldi, Jean‐Christophe Boyer, Fabienne Thomas,

Fundamental and Clinical Pharmacology

2015

108

Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study

Pascaline Boudou‐Rouquette, Céline Narjoz, Jean Louis Golmard,

PLoS ONE

2012

99

APOL1 Polymorphisms and Development of CKD in an Identical Twin Donor and Recipient Pair

Tomek Kofman, Vincent Audard, Céline Narjoz,

American Journal of Kidney Diseases

2014

64

Relation between plasma trough concentration of abiraterone and prostate-specific antigen response in metastatic castration-resistant prostate cancer patients

Edith Carton, Gaëlle Noé, Olivier Huillard,

European Journal of Cancer

2016

63

A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency

Nicolas Pallet, Salma Hamdane, Simon Garinet,

British Journal of Cancer

2020

55

Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients

Céline Narjoz, Anatole Cessot, Audrey Thomas‐Schoemann,

Investigational New Drugs

2014

50

Interindividual Variability in Tpmt Enzyme Activity: 10 Years of Experience with Thiopurine Pharmacogenetics and Therapeutic Drug Monitoring

Laurent Chouchana, Céline Narjoz, Denis Roche,

Pharmacogenomics

2014

49

Roles of <i>APOL1</i> G1 and G2 variants in sickle cell disease patients: kidney is the main target

Raphaël Kormann, Anne‐Sophie Jannot, Céline Narjoz,

British Journal of Haematology

2017

49

Page 1